HUNTSVILLE, Ala. - (Business Wire) Microarrays, Inc. (MI), an innovator of array-based technologies for biological research, detection and diagnostics, today announced that the company’s management team and a group of independent investors have purchased MI from Vanderbilt University. The new company structure will allow MI to more quickly and nimbly respond to client’s rapidly expanding needs, especially within the diagnostic and health care arenas.
MI uses proprietary robotics to manufacture microarrays, orderly arrangements of capture probes usually made of DNA, proteins or other complex organic molecules. These probes are able to “capture” biological information from experimental or clinical samples, allowing researchers to rapidly sort through complex samples and identify the presence or absence of targets of interest, whether for basic research or disease detection. Array-based tools accelerate the rate of discovery by allowing scientists to better understand the fundamental aspects of molecular biology and explore the underlying aspects of human disease. The technology has promising applications in the field of diagnostics, such as sub-typing cancers in an effort to better direct therapies, identification of viral and bacterial pathogens within a patient sample, and personalized medicine.
--- continued ---